Enhanced Group (ENHA) M&A announcement summary

Deal rationale and strategic fit

• Combines owned sports IP and telehealth with DEAG’s European live-event, promoter, venue and proprietary ticketing businesses to build a broader sports and live-entertainment platform.

• DEAG contributes 30+ festivals and ~6,000 annual events across concerts, touring, spoken word and other live experiences; myticket sells over 12 million tickets annually.

• Strategic thesis: AI and automation may free time for authentic, shared in-person experiences.

Financial terms and conditions

• Proposed all-stock acquisition of ~77% of DEAG from Apeiron and other shareholders; consideration is one new share per ~1.7 DEAG shares, with ~11 million new shares issued.

• Terms imply €4.00 per DEAG share and ~€100 million equity value for 100%; the deal also cites ~$115 million equity value and $139.4 million lease-adjusted enterprise value.

• Implied valuation is 5.3x FY2027E lease-adjusted Adjusted EBITDA, versus a 14.1x listed-peer median; estimates are management estimates.

• Concurrent $15 million PIPE planned at $7.11 per share, with common equity and no warrants; proceeds intended for sports, telehealth, performance products, DEAG acquisitions and general corporate purposes.

• Illustrative combined 2027E revenue is $670.0 million and Adjusted EBITDA is $26.1 million; projections consolidate 100% of DEAG, exclude synergies and transaction financing, and are not guidance.

Synergies and expected cost savings

• Pro forma projections include no synergies; cross-selling and other synergies are identified as potential upside.

• Ticketing data and cross-selling across events, sponsorships and consumer products could improve monetization and customer lifetime value.

• Spoken word and ticketing, both described as operating at 20%+ margins, are expected to contribute disproportionately to EBITDA growth; touring and concert promotion are lower-margin growth drivers.